Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex
Reexamination Certificate
1999-03-31
2001-01-30
Tate, Christopher (Department: 1651)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Conjugate or complex
C514S450000, C549S348000
Reexamination Certificate
active
06180105
ABSTRACT:
This invention relates to the production of a novel extract from
Artemisia annua
which contains high levels of the known anti-malarial active Artemisinin. The invention also relates to a method of producing such an extract.
Artemisia annua
has been used in China for many centuries for the treatment of malaria. Research in the 1970s by Chinese scientists confirmed the efficacy of preparations of
Artemisia annua
in the treatment of malaria, including the most severe and life threatening form of the disease known as cerebral malaria, caused by infection with the Plasmodium falciparum parasite. The main chemical constituent of Artemisia responsible for this pharmacological activity was identified as the unusual bridged peroxy sesquiterpene structure originally named “Qinghaosu” but now known as artemisinin. The structure of artemisinin is given below:
Clinical studies on artemisinin and semi-synthetic derivatives such as artemether have confirmed the efficacy of this type of compound in the treatment of malaria. Artemisinin lacks the nitrogen containing heterocyclic ring that is common to the standard anti-malarials currently used such as the aminoquinolines (quinine, chloroquine, primaquine, etc.) The problem of resistance and cross-resistance that is now beginning to seriously limit the effectiveness of these drugs is not observed for artemisinin. For example, artemisinin has been found to be effective against chloroquine resistant strains of
Plasmodium falciparum.
Artemisinin has recently been prepared synthetically but such is the complexity of the molecule that there is no large scale economical synthetic route. This has been recognized by the vigorous research effort directed towards the synthesis of much simpler analogues of artemisinin.
Chinese researchers in their earlier studies favored extracts of Artemisia produced using non-polar organic solvents such as diethyl ether or more commonly, petroleum ether. However, these have the drawbacks that the artemisinin content was quite low and that it was difficult to completely remove trace levels of the solvent to produce a pharmaceutically acceptable product. The extraction process uses large quantities of organic solvent which must either be disposed of or recycled.
In recent years, the use of liquefied carbon dioxide extraction has been applied to the isolation of pharmaceutical actives from plant materials. This technique has been used on an industrial scale for over two decades for the extraction of flavor principles from hops and other herbs and spices. It has the advantage over extraction with conventional organic solvents that the extraction medium is readily and completely removed simply by depressurizing the extraction apparatus, thus allowing the liquid carbon dioxide to vaporize into the atmosphere. Thus, problems of waste solvent disposal and trace solvent contamination of finished product are eliminated. The selectivity of liquid carbon dioxide is generally superior to organic solvents of comparable polarity such as ethyl acetate or petroleum ether.
According to a first aspect of the present invention, a method of preparation of an artemisinin extract comprises the steps of extraction of
Artemisia annua
with solvent comprising liquid carbon dioxide and allowing the carbon dioxide to evaporate from the resultant mixture.
According to a second aspect of the present invention, there is provided an
Artemisia annua
extract containing more than 10% by weight of artemisinin, the extract not containing any residual organic solvent.
A co-solvent may be employed, for example a polar hydroxylic solvent such as C
1
to C
4
alcohol, preferably ethanol. An amount of co-solvent of 5 to 20%, preferably 10% by weight may be employed.
The resultant residual extract may have a high artemisinin content without any traces of residual non-hydroxylic solvent.
Preferred methods involve extraction at a pressure of 1500 to 4500 psi (100 to 310 bars), preferably about 1500 psi (100 bars) and at a temperature in the region of 20 to 50° C., preferably 25 to 30° C. Use of sub-critical carbon dioxide without any co-solvent is preferred.
REFERENCES:
patent: 3477856 (1969-11-01), Schultz
patent: 4554170 (1985-11-01), Panzner et al.
patent: 4632837 (1986-12-01), Schutz et al.
patent: 4985265 (1991-01-01), Duboc et al.
patent: 5413928 (1995-05-01), Weathers et al.
patent: 1095381 (1993-05-01), None
patent: 2317612 (1998-04-01), None
Kohler et al. J. Chromatogr. vol 785, pp. 353-360, 1997.
Kohler et al. Phytochem. Anal. vol. 8, No. 5, pp. 223-227, abstract enclosed, 1997.
Khanan et al. Khim-Farm. Zh. vol. 2, No. 2, pp. 40-44, 1968.
Sigma Chemical Catalog, p. 135 (#A 5430), 1994.
Quellette, R. Intro. to General, Organic, and Biological Chem., 2nd ed., p. 545, 1988.
The Condensed Chem Dictionary, 10th ed., pp. 598 (lactone), 916 (sesquiterpene), 1000 (terpene), 1981.
Grimmett, C. Chemistry and Industry—Food Processing. vol.. 10, pp. 359-362, 1981.
Chemical Abstract No.335344f-Ge et al., Supercritical extraction of arteanniun from Artemisia annua., May 19, 1993.
Hubert et al., Fluid Extraction of Hops, Spices & Tobacco with Supercritical Gases,Agnew. Chem. Int. Ed. Engl., vol. 17, pp. 710-715, 1978.
Moyler, Estraction of Essential Oils with Carbon Dioxide, 23ndInt'l Symposium on Essential Oils, Scotland Sep. 9-12, 1992.
Ronyai et al., Production of Plant Extracts by Supercritical Extraction,Olaj, Szappan, Kozmet, vol. 45, (Special Issue), 1996.
CN 1095381 A (GE et al.) Abstract only., 1994.
Chem Abstr. (23:335344f, 1993.
Chapman Thomas Brian
Wheatley Gary William
Essential Nutrition Ltd.
Jenkens & Gilchrist A Professional Corporation
Tate Christopher
LandOfFree
Method for producing an extract containing artemesinin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for producing an extract containing artemesinin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for producing an extract containing artemesinin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2463029